Cargando…
Untreated anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia progressing over 27 years
Autores principales: | Schegk, E., Beiser, I., Achtnichts, L., Nedeltchev, K., Bertschi, M., Gschwind, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188403/ https://www.ncbi.nlm.nih.gov/pubmed/36856845 http://dx.doi.org/10.1007/s00415-023-11632-2 |
Ejemplares similares
-
Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia
por: Jarius, Sven, et al.
Publicado: (2013) -
Anti-ARHGAP26 Autoantibodies Are Associated With Isolated Cognitive Impairment
por: Bartels, Frederik, et al.
Publicado: (2018) -
Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis
por: Jarius, Sven, et al.
Publicado: (2022) -
‘Medusa head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC
por: Jarius, S., et al.
Publicado: (2015) -
Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias
por: Mitoma, Hiroshi, et al.
Publicado: (2017)